| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |